Loading...
cbdMD, Inc.
YCBD•AMEX
Healthcare
Drug Manufacturers - Specialty & Generic
$0.95
$0.02(2.15%)
cbdMD, Inc. (YCBD) Financial Performance & Income Statement Overview
Review cbdMD, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-19.35%
↓ 19.35%
Operating Income Growth
65.59%
↑ 65.59%
Net Income Growth
83.87%
↑ 83.87%
Operating Cash Flow Growth
91.80%
↑ 91.80%
Operating Margin
-6.49%
↓ 6.49%
Gross Margin
62.35%
↑ 62.35%
Net Profit Margin
-5.92%
↓ 5.92%
ROE
-0.69%
↓ 0.69%
ROIC
0.01%
↑ 0.01%
cbdMD, Inc. (YCBD) Income Statement & Financial Overview
Review cbdMD, Inc.'s (YCBD) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $5.11M | $4.56M | $5.17M | $4.38M |
| Cost of Revenue | $1.71M | $2.10M | $1.77M | $1.80M |
| Gross Profit | $3.40M | $2.45M | $3.40M | $2.58M |
| Gross Profit Ratio | $0.67 | $0.54 | $0.66 | $0.59 |
| R&D Expenses | $0.00 | $22186.00 | $0.00 | $2097.00 |
| SG&A Expenses | $2.73M | $2.76M | $3.03M | $3.78M |
| Operating Expenses | $3.49M | $2.77M | $3.79M | $4.13M |
| Total Costs & Expenses | -$5.20M | $4.87M | $5.56M | $5.93M |
| Interest Income | $11404.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $12741.00 | $18399.00 |
| Depreciation & Amortization | $339138.00 | $76005.00 | $585579.00 | $584707.00 |
| EBITDA | $354233.00 | $488142.00 | $1.06M | -$2.41M |
| EBITDA Ratio | $0.07 | $0.11 | $0.20 | -$0.55 |
| Operating Income | -$86.27M | -$316555.00 | -$382028.00 | -$1.55M |
| Operating Income Ratio | -$16.87 | -$0.07 | -$0.07 | -$0.35 |
| Other Income/Expenses (Net) | $101.37M | $163756.00 | $841765.00 | -$1.46M |
| Income Before Tax | $15.10M | -$152799.00 | $459737.00 | -$3.01M |
| Income Before Tax Ratio | $2.95 | -$0.03 | $0.09 | -$0.69 |
| Income Tax Expense | $1.001B | $0.00 | $0.00 | $1.000M |
| Net Income | $15095.00 | -$152799.00 | $459737.00 | -$4.01M |
| Net Income Ratio | $0.003 | -$0.03 | $0.09 | -$0.92 |
| EPS | -$0.22 | $1.52 | -$0.15 | -$1.35 |
| Diluted EPS | -$0.22 | $1.52 | -$0.15 | -$1.35 |
| Weighted Avg Shares Outstanding | $4.55M | $4.31M | $3.59M | $2.96M |
| Weighted Avg Shares Outstanding (Diluted) | $4.55M | $4.31M | $3.59M | $2.96M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan